ghk-cu injections ghk cu 3 times a week isn't about instant change. It's about cellular ghk-cu peptide dosing frequency ghk

Which approach fits depends on whether the ratio is a variable under study or a constant

Administer different peptides separately rather than mixing in one syringe

Any effects discussed are based on research and user reports

Presented for research literature review only Stupnisek M et al

WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use

It may help with wound healing, reduce inflammation, and improve overall tissue regeneration